Federal Register / Vol. 61, No. 17 / Thursday, January 25, 1996 / Notices 2257

92–463, the meeting will be closed to

the public for the review, discussion,

and evaluation of individual grant

applications and contract proposals

from 9:30 a.m. until recess on February

6, and from 8:30 a.m. until adjournment

on February 7. These applications,

proposals, and the discussion could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with

the applications and proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

Ms. Claudia Goad, Committee

Management Officer, National Institute

of Allergy and Infectious Diseases, Solar

Building, Room 3C26, National

Institutes of Health, Bethesda, Maryland

20892, 301–496–7601, will provide a

summary of the meeting and a roster of

committee members upon request.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. Goad in advance of the

meeting.

Dr. Kevin M. Callahan, Scientific

Review Administrator, Allergy,

Immunology and Transplantation

Research Committee, NIAID, NIH, Solar

Building, Room 4C20, Bethesda,

Maryland 20892, telephone 301–496–

8424, will provide substantive program

information.

This notice is being published less

than 15 days prior to the above meeting

due to the partial shutdown of the

Federal Government and the urgent

need to meet timing limitations imposed

by the review and funding cycle.

(Catalog of Federal Domestic Assistance

Program Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research,

National Institutes of Health.)

Dated: January 19, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–1133 Filed 1–24–96; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

National Arthritis and Musculoskeletal

and Skin Diseases Advisory Council;

Notice of Meeting

Pursuant to Pub. L. 92–463, notice is

hereby given of a meeting of the

National Arthritis and Musculoskeletal

and Skin Diseases Advisory Council to

provide advice to the National Institute

of Arthritis and Musculoskeletal and

Skin Diseases on February 8, 1996,

Wilson Hall, Shannon Building,

National Institutes of Health, Bethesda,

Maryland.

The meeting will be open to the

public February 8 from 8:30 a.m. to 9:00

a.m. to discuss administrative details

relating to Council business and special

reports. Attendance by the public will

be limited to space available.

The meeting of the Advisory Council

will be closed to the public on February

8 from 9:00 a.m. to adjournment in

accordance with provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5,

U.S.C. and sec. 10(d) of Pub. L. 92–463,

for the review, discussion and

evaluation of individual grant

applications. These deliberations could

reveal confidential trade secrets or

commercial property, such as patentable

materials, and personal information

concerning individuals associated with

the applications, disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Dr. Steven Hausman, Executive

Secretary, National Arthritis and

Musculoskeletal and Skin Diseases

Advisory Council, NIAMS, Natcher

Building, Room 5AS–13, Bethesda,

Maryland 20892, (301) 594–2463.

A summary of the meeting and roster

of the members may be obtained from

the Extramural Programs Office,

NIAMS, Natcher Bldg, Rm. 5AS–13,

National Institute of Health, Bethesda,

Maryland 20892, (301) 594–2463.

(Catalog of Federal Domestic Assistance

Program No. 93.846, Arthritis, Bone and Skin

Diseases, National Institutes of Health)

Dated: January 18, 1996.

Susan K. Feldman,

NIH Committee Management Officer.

[FR Doc. 96–1134 Filed 1–24–96; 8:45 am]

BILLING CODE 4140–01–M

National Institute on Drug Abuse;

Notice of Meeting

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

National Advisory Council on Drug

Abuse, National Institute on Drug Abuse

on February 6–7, 1996.

On February 6, from 9 a.m. to 2 p.m.,

the meeting will be held at the National

Institutes of Health, Building 1, Wilson

Hall, 9000 Rockville Pike, Bethesda,

Maryland 20892. In accordance with

provisions set forth in sec. 552b(c)(4)

and 552b(c)(6), Title 5, U.S.C. and sec.

10(d) of Pub. L. 92–463, this portion of

the meeting will be closed to the public

for the review, discussion, and

evaluation of grant applications. These

applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with

the applications, disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

On February 7, from 9 a.m. to 5 p.m.,

the meeting will be held at the Parklawn

Building, Conference Room G, 5600

Fishers Lane, Rockville, MD 20857. This

portion of the meeting will be open to

the public for announcements and

reports of administrative, legislative,

and program developments in the drug

abuse field. Attendance by the public

will be limited to space available.

A summary of the meeting and a

roster of committee members may be

obtained from Ms. Camilla L. Holland,

NIDA Committee Management Officer,

National Institutes of Health, Parklawn

Building, Room 10–42, 5600 Fishers

Land, Rockville, Maryland 20857 (301/

443–2755).

Substantive program information may

be obtained from Ms. Eleanor C.

Friedenberg, Room 10–42, Parklawn

Building, 5600 Fishers Lane, Rockville,

Maryland 20857, (301/443–2755).

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact the contact person named above

in advance of the meeting.

This notice is being published less

than 15 days prior to the above meeting

due to the partial shutdown of the

Federal Government and the urgent

need to meet timing limitations imposed

by the review and funding cycle.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.277, Drug Abuse

Research Scientist Development and

Research Scientist Awards; 93.278, Drug

Abuse National Research Service Awards for

Research Training; 93.279, Drug Abuse

Research Programs.)

Dated: January 18, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–1132 Filed 1–24–96; 8:45 am]

BILLING CODE 4140–01–M

National Library of Medicine; Notice of

Meeting of the Biomedical Library

Review Committee

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

Biomedical Library Review Committee

on March 6–7, 1996, convening at 8:30

a.m. in the Board Room of the National

Library of Medicine, Building 38, 8600

Rockville Pike, Bethesda, Maryland.